José Ramón
González Porras
Profesor Asociado CC. Salud
Hospital Universitario de Valladolid
Valladolid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Valladolid (11)
2023
-
Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
Blood, Vol. 141, Núm. 4, pp. 406-421
2018
-
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders
Haematologica, Vol. 103, Núm. 1, pp. 148-162
2017
-
Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes
Thrombosis and Haemostasis, Vol. 117, Núm. 1, pp. 66-74
-
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516
2016
-
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders
Haemophilia, Vol. 22, Núm. 4, pp. 590-597
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302
-
Identification of a new potential mechanism responsible for severe bleeding in myeloma: Immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant
Haematologica
-
Questionários autoadministrados versus administrados por entrevistador para pacientes com claudicação intermitente: Os resultados são diferentes? Um estudo transversal
Sao Paulo Medical Journal, Vol. 134, Núm. 1, pp. 63-69
2015
-
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43
-
Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia
Platelets, Vol. 26, Núm. 1, pp. 83-86
2013
-
Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia
European Journal of Haematology, Vol. 91, Núm. 3, pp. 236-241